Russia launches Ebola vaccine production

NOVOSIBIRSK, October 24. /TASS/. Russia has launched the production of a trial batch of the Ebola vaccine Triazavirin that will be sent to Africa in the coming days to test its efficiency, head of the vaccine producer Yunona (Juno) pharmaceutical holding Aleksandr Petrov said on Friday. The vaccine was created by the Ural Biopharmaceutical Technology Centre. Triazavirin has been approved by the Russian Health Ministry, Petrov said. “Studies have confirmed the medicine’s high efficiency against a number of viral infections - influenza, tick-borne encephalitis and exotic viruses that are common in Africa and Asia,” the scientist said. Russian Deputy Prime Minister Olga Golodets said on October 13 that Russian specialists were close to completion of the work to create the Ebola fever vaccine. Tests of Triazavirin have shown the vaccine’s high efficiency (70 to 90 percent) against various kinds of haemorrhagic fevers, including Marburg fever, which has a close relation to Ebola. Learn more on tass.ru